Home › Free Stock Grades › GKOS
Glaukos Corporation (GKOS) Stock Grade
GKOS · Healthcare
C
Market Cap
$9.4B
P/E Ratio
—
Revenue Growth (YoY)
+32.3%
Net Margin
-37.0%
Return on Equity
—
Dividend Yield
None
About Glaukos Corporation's fundamentals
Glaukos Corporation is a medical device company with a $9.4 billion market capitalization that is experiencing strong revenue growth of 32.3% year-over-year. However, the company is currently unprofitable, with a net margin of -37.0% and reported a net loss in its latest annual statement, meaning expenses exceed revenues. The company does not pay a dividend to shareholders. Glaukos' growth trajectory suggests expanding market presence, though investors should note the company has not yet achieved profitability.